Name: Global Infectious Disease Point of Care Diagnostics Market Insights, Forecast to 2035
Brand: Extent Research
Price: 3500 USD
Availability: InStock
Rating: 5.0 (160 reviews)

Global Infectious Disease Point of Care Diagnostics Market

Market Size in USD Billion

CAGR : 17.60%

USD 1.14

2025

USD 4.17

2033

Forecast Period	2025 - 2033
Market Size (Base Year)	USD 1.14 Billion
Market Size (Forecast)	USD 4.17 Billion
CAGR	17.60%
Major Market Players	Data provided in full report

EXTENT RESEARCH offers authentic industry insights and comprehensive information-loaded market reports to all the pre-established companies and startups. The market research experts available at EXTENT RESEARCH guide their clients to strategize corporate policies, which would help them accomplish sustainable growth in their respective sectors. The staff at the organization including data collection, research, publishing, and consulting teams work in collaboration to offer hassle-free services to the clients. The global Infectious Disease Point of Care Diagnostics Market report illustrates the key emphasis such as strategies, business forecast, future predictions, consumer surveys, and opportunity analysis, among others.

Data provided by Extent Research. Source: https://www.extentresearch.com/infectious-disease-point-of-care-diagnostics-market

Crucial Pieces Of Information Inculcated In The Global Infectious Disease Point of Care Diagnostics Market Report:

Global Infectious Disease Point of Care Diagnostics market capitalization, size, CAGR, revenue generation, profits or losses incurred, manufacturing capability, and sales.
Global Infectious Disease Point of Care Diagnostics market size evaluation based on the plausible segments Product type Over-the-counter (OTC) Testing Kits, Prescription-based Testing Kits, by Application Bacterial Infections, Fungal Infection, Virus Infection, Cardiovascular Infection, Gastrointestinal Infection, Sexually Transmitted Disease (STD) Infection, Central Nervous System Infection, Other, .
Summarized data of qualitative and quantitative research conducted on the multifarious industries belong to the Infectious Disease Point of Care Diagnostics sector.
Size, share, and important fiscal information of the individual key contenders Abbott, Siemens, GE Healthcare, Accriva, Terumo, BioMerieux, Diasorin, Roche, Danaher Corporation, BD, Bio-Rad Laboratories, Cavidi, Cepheid, Diaxonhit, Eiken Chemical, EMD Millipore, Epitope Diagnostic, Euroimmun, Gold Standard Diagnostics, Hologic, Immunetics, InBios International, driving the global Infectious Disease Point of Care Diagnostics market.
Potential business-related threats for the novice or startups owing to the overdominance of the full-fledged industries.
Offers key information related to supply chain management, precise futuristic predictions, multifarious strategies to impel productivity & demand, current & forthcoming trends in the Infectious Disease Point of Care Diagnostics business, and product evaluation.
The global Infectious Disease Point of Care Diagnostics report depicts the key growth and restraints that fluctuate the performance of the industries.
The report highlights sensible reasons why a specific region is overshadowing in terms of production, sales, and revenue generation.
Impact of COVID-19 along with some robust strategies that industries can implement to mitigate the long-term effects of the pandemic.

In case of any doubts or queries, please feel free to contact our team by clicking on the link and schedule an appointment with one of our experts.

Report Scope and Market Segmentation

ATTRIBUTES	Global Infectious Disease Point of Care Diagnostics Market KEY MARKET INSIGHTS
Segments Covered	By Product Type: All Products Type Includes By Application: All Application Type Includes By End User: All End User Type Includes By Distribution Channel: All Distribution Channel Includes
Countries Covered	North America U.S., Canada, Mexico Europe Germany, United Kingdom, France, Italy, Spain, Nordic Countries, Benelux Union, Rest of Europe Asia-Pacific China, India, Japan, New Zealand, South Korea, Australia, Southeast Asia, Rest of Asia Pacific Latin America Brazil, Argentina, Rest of Latin America Middle East & Africa Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa
Key Market Players	Leading Tier 1 Corporations Prominent Regional Manufacturers Emerging Market Disruptors Technology Integrators & Suppliers *Complete vendor layout of 15+ major players provided in the final report.
Market Opportunities	Market Size and Growth: Quantifying the total addressable market (TAM) and projected growth rates to assess financial viability. Customer Segmentation: Identifying target audience behaviors, pain points, and specific unfulfilled demands. Competitive Landscape: Analyzing existing competitors' strengths, weaknesses, and market share to pinpoint gaps and opportunities. Industry Trends: Mapping technological, regulatory, and economic shifts that create favorable conditions for market entry. Risk Assessment: Evaluating barriers to entry and operational challenges alongside strategic roadmaps for mitigation.
Value Added Data Infosets	In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by our expert team also include in-depth expert analysis, geographically represented company-wise production and capacity, network layouts of distributors and partners, detailed and updated price trend analysis and deficit analysis of supply chain and demand.

Meet the Team

Julie

Author

Julie Jayne is a distinguished multidisciplinary strategist and the Head of Research at Extent Research, where she leverages over a decade of comprehensive experience in the global market intelligence industry. Backed by a robust academic foundation that includes a B.Sc. and an MBA, she perfectly...

Priya M

Reviewed By

With over 14 years of dedicated professional expertise in business-to-business (B2B) intelligence, Priya M stands as a distinguished leader in corporate strategy, revenue growth, and advanced data analysis. Her dynamic career is defined by a relentless focus on mitigating business risks and empowering corporate executives...

Learn more about Priya M

BASIC ATTRIBUTES \| KEY MARKET INSIGHTS
Report Title	Global Infectious Disease Point of Care Diagnostics Market
Base Year	2025
Forecast Period	2025 - 2033
Market Size (Base)	USD 1.14 Billion
Projected Size	USD 4.17 Billion
CAGR	17.60%

                            1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Infectious Disease Point of Care Diagnostics Market Size Growth Rate by Type, 2017 VS 2021 VS 2035
        1.2.2 Over-the-counter (OTC) Testing Kits
        1.2.3 Prescription-based Testing Kits
    1.3 Market by Application
        1.3.1 Global Infectious Disease Point of Care Diagnostics Market Size Growth Rate by Application, 2017 VS 2021 VS 2035
        1.3.2 Bacterial Infections
        1.3.3 Fungal Infection
        1.3.4 Virus Infection
        1.3.5 Cardiovascular Infection
        1.3.6 Gastrointestinal Infection
        1.3.7 Sexually Transmitted Disease (STD) Infection
        1.3.8 Central Nervous System Infection
        1.3.9 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Infectious Disease Point of Care Diagnostics Market Perspective (2017-2035)
    2.2 Infectious Disease Point of Care Diagnostics Growth Trends by Region
        2.2.1 Infectious Disease Point of Care Diagnostics Market Size by Region: 2017 VS 2021 VS 2035
        2.2.2 Infectious Disease Point of Care Diagnostics Historic Market Size by Region (2017-2022)
        2.2.3 Infectious Disease Point of Care Diagnostics Forecasted Market Size by Region (2023-2035)
    2.3 Infectious Disease Point of Care Diagnostics Market Dynamics
        2.3.1 Infectious Disease Point of Care Diagnostics Industry Trends
        2.3.2 Infectious Disease Point of Care Diagnostics Market Drivers
        2.3.3 Infectious Disease Point of Care Diagnostics Market Challenges
        2.3.4 Infectious Disease Point of Care Diagnostics Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Infectious Disease Point of Care Diagnostics Players by Revenue
        3.1.1 Global Top Infectious Disease Point of Care Diagnostics Players by Revenue (2017-2022)
        3.1.2 Global Infectious Disease Point of Care Diagnostics Revenue Market Share by Players (2017-2022)
    3.2 Global Infectious Disease Point of Care Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Infectious Disease Point of Care Diagnostics Revenue
    3.4 Global Infectious Disease Point of Care Diagnostics Market Concentration Ratio
        3.4.1 Global Infectious Disease Point of Care Diagnostics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Infectious Disease Point of Care Diagnostics Revenue in 2021
    3.5 Infectious Disease Point of Care Diagnostics Key Players Head office and Area Served
    3.6 Key Players Infectious Disease Point of Care Diagnostics Product Solution and Service
    3.7 Date of Enter into Infectious Disease Point of Care Diagnostics Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Infectious Disease Point of Care Diagnostics Breakdown Data by Type
    4.1 Global Infectious Disease Point of Care Diagnostics Historic Market Size by Type (2017-2022)
    4.2 Global Infectious Disease Point of Care Diagnostics Forecasted Market Size by Type (2023-2035)
5 Infectious Disease Point of Care Diagnostics Breakdown Data by Application
    5.1 Global Infectious Disease Point of Care Diagnostics Historic Market Size by Application (2017-2022)
    5.2 Global Infectious Disease Point of Care Diagnostics Forecasted Market Size by Application (2023-2035)
6 North America
    6.1 North America Infectious Disease Point of Care Diagnostics Market Size (2017-2035)
    6.2 North America Infectious Disease Point of Care Diagnostics Market Size by Type
        6.2.1 North America Infectious Disease Point of Care Diagnostics Market Size by Type (2017-2022)
        6.2.2 North America Infectious Disease Point of Care Diagnostics Market Size by Type (2023-2035)
        6.2.3 North America Infectious Disease Point of Care Diagnostics Market Share by Type (2017-2035)
    6.3 North America Infectious Disease Point of Care Diagnostics Market Size by Application
        6.3.1 North America Infectious Disease Point of Care Diagnostics Market Size by Application (2017-2022)
        6.3.2 North America Infectious Disease Point of Care Diagnostics Market Size by Application (2023-2035)
        6.3.3 North America Infectious Disease Point of Care Diagnostics Market Share by Application (2017-2035)
    6.4 North America Infectious Disease Point of Care Diagnostics Market Size by Country
        6.4.1 North America Infectious Disease Point of Care Diagnostics Market Size by Country (2017-2022)
        6.4.2 North America Infectious Disease Point of Care Diagnostics Market Size by Country (2023-2035)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Infectious Disease Point of Care Diagnostics Market Size (2017-2035)
    7.2 Europe Infectious Disease Point of Care Diagnostics Market Size by Type
        7.2.1 Europe Infectious Disease Point of Care Diagnostics Market Size by Type (2017-2022)
        7.2.2 Europe Infectious Disease Point of Care Diagnostics Market Size by Type (2023-2035)
        7.2.3 Europe Infectious Disease Point of Care Diagnostics Market Share by Type (2017-2035)
    7.3 Europe Infectious Disease Point of Care Diagnostics Market Size by Application
        7.3.1 Europe Infectious Disease Point of Care Diagnostics Market Size by Application (2017-2022)
        7.3.2 Europe Infectious Disease Point of Care Diagnostics Market Size by Application (2023-2035)
        7.3.3 Europe Infectious Disease Point of Care Diagnostics Market Share by Application (2017-2035)
    7.4 Europe Infectious Disease Point of Care Diagnostics Market Size by Country
        7.4.1 Europe Infectious Disease Point of Care Diagnostics Market Size by Country (2017-2022)
        7.4.2 Europe Infectious Disease Point of Care Diagnostics Market Size by Country (2023-2035)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Infectious Disease Point of Care Diagnostics Market Size (2017-2035)
    8.2 Asia-Pacific Infectious Disease Point of Care Diagnostics Market Size by Type
        8.2.1 Asia-Pacific Infectious Disease Point of Care Diagnostics Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Infectious Disease Point of Care Diagnostics Market Size by Type (2023-2035)
        8.2.3 Asia-Pacific Infectious Disease Point of Care Diagnostics Market Share by Type (2017-2035)
    8.3 Asia-Pacific Infectious Disease Point of Care Diagnostics Market Size by Application
        8.3.1 Asia-Pacific Infectious Disease Point of Care Diagnostics Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Infectious Disease Point of Care Diagnostics Market Size by Application (2023-2035)
        8.3.3 Asia-Pacific Infectious Disease Point of Care Diagnostics Market Share by Application (2017-2035)
    8.4 Asia-Pacific Infectious Disease Point of Care Diagnostics Market Size by Region
        8.4.1 Asia-Pacific Infectious Disease Point of Care Diagnostics Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Infectious Disease Point of Care Diagnostics Market Size by Region (2023-2035)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Infectious Disease Point of Care Diagnostics Market Size (2017-2035)
    9.2 Latin America Infectious Disease Point of Care Diagnostics Market Size by Type
        9.2.1 Latin America Infectious Disease Point of Care Diagnostics Market Size by Type (2017-2022)
        9.2.2 Latin America Infectious Disease Point of Care Diagnostics Market Size by Type (2023-2035)
        9.2.3 Latin America Infectious Disease Point of Care Diagnostics Market Share by Type (2017-2035)
    9.3 Latin America Infectious Disease Point of Care Diagnostics Market Size by Application
        9.3.1 Latin America Infectious Disease Point of Care Diagnostics Market Size by Application (2017-2022)
        9.3.2 Latin America Infectious Disease Point of Care Diagnostics Market Size by Application (2023-2035)
        9.3.3 Latin America Infectious Disease Point of Care Diagnostics Market Share by Application (2017-2035)
    9.4 Latin America Infectious Disease Point of Care Diagnostics Market Size by Country
        9.4.1 Latin America Infectious Disease Point of Care Diagnostics Market Size by Country (2017-2022)
        9.4.2 Latin America Infectious Disease Point of Care Diagnostics Market Size by Country (2023-2035)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size (2017-2035)
    10.2 Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size by Type
        10.2.1 Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size by Type (2023-2035)
        10.2.3 Middle East & Africa Infectious Disease Point of Care Diagnostics Market Share by Type (2017-2035)
    10.3 Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size by Application
        10.3.1 Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size by Application (2023-2035)
        10.3.3 Middle East & Africa Infectious Disease Point of Care Diagnostics Market Share by Application (2017-2035)
    10.4 Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size by Country
        10.4.1 Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Infectious Disease Point of Care Diagnostics Market Size by Country (2023-2035)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Abbott
        11.1.1 Abbott Company Details
        11.1.2 Abbott Business Overview
        11.1.3 Abbott Infectious Disease Point of Care Diagnostics Introduction
        11.1.4 Abbott Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022)
        11.1.5 Abbott Recent Developments
    11.2 Siemens
        11.2.1 Siemens Company Details
        11.2.2 Siemens Business Overview
        11.2.3 Siemens Infectious Disease Point of Care Diagnostics Introduction
        11.2.4 Siemens Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022)
        11.2.5 Siemens Recent Developments
    11.3 GE Healthcare
        11.3.1 GE Healthcare Company Details
        11.3.2 GE Healthcare Business Overview
        11.3.3 GE Healthcare Infectious Disease Point of Care Diagnostics Introduction
        11.3.4 GE Healthcare Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022)
        11.3.5 GE Healthcare Recent Developments
    11.4 Accriva
        11.4.1 Accriva Company Details
        11.4.2 Accriva Business Overview
        11.4.3 Accriva Infectious Disease Point of Care Diagnostics Introduction
        11.4.4 Accriva Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022)
        11.4.5 Accriva Recent Developments
    11.5 Terumo
        11.5.1 Terumo Company Details
        11.5.2 Terumo Business Overview
        11.5.3 Terumo Infectious Disease Point of Care Diagnostics Introduction
        11.5.4 Terumo Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022)
        11.5.5 Terumo Recent Developments
    11.6 BioMerieux
        11.6.1 BioMerieux Company Details
        11.6.2 BioMerieux Business Overview
        11.6.3 BioMerieux Infectious Disease Point of Care Diagnostics Introduction
        11.6.4 BioMerieux Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022)
        11.6.5 BioMerieux Recent Developments
    11.7 Diasorin
        11.7.1 Diasorin Company Details
        11.7.2 Diasorin Business Overview
        11.7.3 Diasorin Infectious Disease Point of Care Diagnostics Introduction
        11.7.4 Diasorin Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022)
        11.7.5 Diasorin Recent Developments
    11.8 Roche
        11.8.1 Roche Company Details
        11.8.2 Roche Business Overview
        11.8.3 Roche Infectious Disease Point of Care Diagnostics Introduction
        11.8.4 Roche Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022)
        11.8.5 Roche Recent Developments
    11.9 Danaher Corporation
        11.9.1 Danaher Corporation Company Details
        11.9.2 Danaher Corporation Business Overview
        11.9.3 Danaher Corporation Infectious Disease Point of Care Diagnostics Introduction
        11.9.4 Danaher Corporation Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022)
        11.9.5 Danaher Corporation Recent Developments
    11.10 BD
        11.10.1 BD Company Details
        11.10.2 BD Business Overview
        11.10.3 BD Infectious Disease Point of Care Diagnostics Introduction
        11.10.4 BD Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022)
        11.10.5 BD Recent Developments
    11.11 Bio-Rad Laboratories
        11.11.1 Bio-Rad Laboratories Company Details
        11.11.2 Bio-Rad Laboratories Business Overview
        11.11.3 Bio-Rad Laboratories Infectious Disease Point of Care Diagnostics Introduction
        11.11.4 Bio-Rad Laboratories Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022)
        11.11.5 Bio-Rad Laboratories Recent Developments
    11.12 Cavidi
        11.12.1 Cavidi Company Details
        11.12.2 Cavidi Business Overview
        11.12.3 Cavidi Infectious Disease Point of Care Diagnostics Introduction
        11.12.4 Cavidi Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022)
        11.12.5 Cavidi Recent Developments
    11.13 Cepheid
        11.13.1 Cepheid Company Details
        11.13.2 Cepheid Business Overview
        11.13.3 Cepheid Infectious Disease Point of Care Diagnostics Introduction
        11.13.4 Cepheid Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022)
        11.13.5 Cepheid Recent Developments
    11.14 Diaxonhit
        11.14.1 Diaxonhit Company Details
        11.14.2 Diaxonhit Business Overview
        11.14.3 Diaxonhit Infectious Disease Point of Care Diagnostics Introduction
        11.14.4 Diaxonhit Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022)
        11.14.5 Diaxonhit Recent Developments
    11.15 Eiken Chemical
        11.15.1 Eiken Chemical Company Details
        11.15.2 Eiken Chemical Business Overview
        11.15.3 Eiken Chemical Infectious Disease Point of Care Diagnostics Introduction
        11.15.4 Eiken Chemical Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022)
        11.15.5 Eiken Chemical Recent Developments
    11.16 EMD Millipore
        11.16.1 EMD Millipore Company Details
        11.16.2 EMD Millipore Business Overview
        11.16.3 EMD Millipore Infectious Disease Point of Care Diagnostics Introduction
        11.16.4 EMD Millipore Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022)
        11.16.5 EMD Millipore Recent Developments
    11.17 Epitope Diagnostic
        11.17.1 Epitope Diagnostic Company Details
        11.17.2 Epitope Diagnostic Business Overview
        11.17.3 Epitope Diagnostic Infectious Disease Point of Care Diagnostics Introduction
        11.17.4 Epitope Diagnostic Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022)
        11.17.5 Epitope Diagnostic Recent Developments
    11.18 Euroimmun
        11.18.1 Euroimmun Company Details
        11.18.2 Euroimmun Business Overview
        11.18.3 Euroimmun Infectious Disease Point of Care Diagnostics Introduction
        11.18.4 Euroimmun Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022)
        11.18.5 Euroimmun Recent Developments
    11.19 Gold Standard Diagnostics
        11.19.1 Gold Standard Diagnostics Company Details
        11.19.2 Gold Standard Diagnostics Business Overview
        11.19.3 Gold Standard Diagnostics Infectious Disease Point of Care Diagnostics Introduction
        11.19.4 Gold Standard Diagnostics Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022)
        11.19.5 Gold Standard Diagnostics Recent Developments
    11.20 Hologic
        11.20.1 Hologic Company Details
        11.20.2 Hologic Business Overview
        11.20.3 Hologic Infectious Disease Point of Care Diagnostics Introduction
        11.20.4 Hologic Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022)
        11.20.5 Hologic Recent Developments
    11.21 Immunetics
        11.21.1 Immunetics Company Details
        11.21.2 Immunetics Business Overview
        11.21.3 Immunetics Infectious Disease Point of Care Diagnostics Introduction
        11.21.4 Immunetics Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022)
        11.21.5 Immunetics Recent Developments
    11.22 InBios International
        11.22.1 InBios International Company Details
        11.22.2 InBios International Business Overview
        11.22.3 InBios International Infectious Disease Point of Care Diagnostics Introduction
        11.22.4 InBios International Revenue in Infectious Disease Point of Care Diagnostics Business (2017-2022)
        11.22.5 InBios International Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer                        

Research Methodology

Data collection and base year analysis are done using proprietary data collection modules with large sample sizes. The process includes obtaining market information through extensive secondary sources, paid databases, and verifying data via primary (industry expert) validation.

Our market models include Vendor Positioning Grids, Market Timeline Analysis, Company Market Share Analysis, and Top-Down/Bottom-Up forecasting models. To know more about the research methodology, drop an inquiry to speak to our industry experts.

Speak to Analyst

Global Infectious Disease Point of Care Diagnostics Market